---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-043580"
form_type: "8-K"
ticker: "ALLR"
cik: "0001860657"
company_name: "Allarity Therapeutics, Inc."
filed_at: "2023-05-26T23:59:59+00:00"
generated_at: "2026-06-14T13:26:03.118958+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Allarity receives Nasdaq additional delisting basis for bid price non-compliance; panel to decide

## Summary
- Received Nasdaq letter on May 23, 2023 confirming failure to regain $1.00 minimum bid price by May 22, 2023 deadline.
- Bid price non-compliance will serve as an additional basis for delisting, considered by Hearings Panel.
- Panel heard Company's appeal on May 18, 2023 regarding stockholders' equity requirement non-compliance.
- Company will provide additional information to Panel by required timeframe to support continued listing.

## SEC filing metadata
- accession: 0001213900-23-043580
- form_type: 8-K
- ticker: ALLR
- cik: 0001860657
- company_name: Allarity Therapeutics, Inc.
- filed_at: 2023-05-26T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1860657/000121390023043580/0001213900-23-043580-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1860657/000121390023043580/ea179363-8k_allarity.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-043580
- JSON: https://secwatch.observer/filing/0001213900-23-043580.json
- Plain text: https://secwatch.observer/filing/0001213900-23-043580.txt

## Key facts
- Listing & Compliance Notices
  Allarity Therapeutics, Inc. received a nasdaq delisting notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).
  - Exchange: nasdaq
  - Notice: delisting notice
  - Deficiency: minimum bid price
  - Rules: 5450(a)(1), 5810(c)(3)(A)
  source text: May 23, 2023, the Company received a letter from the Nasdaq Regulation staff (“Letter”) stating that the Company did not regain compliance under the Rule by May 22, 2023, and such non-compliance will serve as an additional basis for delisting of the Company’s common stock from The Nasdaq Stock Market. Further, the Nasdaq Hearings Panel, which on May 18, 2023, heard the Company’s appeal for non-compliance with the stockholders’ equity requirement as set forth in Nasdaq Listing Rule 5450(b)(1)(A), will consider the Letter in their decision regarding the Company’s continued listing on The Nasdaq
  evidence_url: https://www.sec.gov/Archives/edgar/data/1860657/000121390023043580/0001213900-23-043580-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.